BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 16860160)

  • 1. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
    Biniwale MA; Ehrenkranz RA
    Semin Perinatol; 2006 Aug; 30(4):200-8. PubMed ID: 16860160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants.
    Wang LY; Luo HJ; Hsieh WS; Hsu CH; Hsu HC; Chen PS; Chiu NC; Lee WT; Jeng SF
    Pediatr Pulmonol; 2010 Feb; 45(2):165-73. PubMed ID: 20054861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special circumstances: trophic feeds, necrotizing enterocolitis and bronchopulmonary dysplasia.
    Reynolds RM; Thureen PJ
    Semin Fetal Neonatal Med; 2007 Feb; 12(1):64-70. PubMed ID: 17189719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional strategies and growth in extremely low birth weight infants with bronchopulmonary dysplasia over the past 10 years.
    Theile AR; Radmacher PG; Anschutz TW; Davis DW; Adamkin DH
    J Perinatol; 2012 Feb; 32(2):117-22. PubMed ID: 21617642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition and feeding in infants with bronchopulmonary dysplasia after initial hospital discharge: risk factors for growth failure.
    Johnson DB; Cheney C; Monsen ER
    J Am Diet Assoc; 1998 Jun; 98(6):649-56. PubMed ID: 9627622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants.
    Dinerstein A; Nieto RM; Solana CL; Perez GP; Otheguy LE; Larguia AM
    J Perinatol; 2006 Jul; 26(7):436-42. PubMed ID: 16801958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia.
    Ambalavanan N; Carlo WA
    Semin Perinatol; 2006 Aug; 30(4):192-9. PubMed ID: 16860159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
    Schmidt B; Roberts R; Millar D; Kirpalani H
    Neonatology; 2008; 93(4):284-7. PubMed ID: 18525211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of infants with bronchopulmonary dysplasia in North America.
    Bancalari E; Wilson-Costello D; Iben SC
    Early Hum Dev; 2005 Feb; 81(2):171-9. PubMed ID: 15748972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side effects and long-term follow-up of corticosteroid therapy in very low birthweight infants with bronchopulmonary dysplasia.
    Ferrara TB; Couser RJ; Hoekstra RE
    J Perinatol; 1990 Jun; 10(2):137-42. PubMed ID: 2358896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing issues in the intensive care for the periviable infant--nutritional management and prevention of bronchopulmonary dysplasia and nosocomial infections.
    Ehrenkranz RA
    Semin Perinatol; 2014 Feb; 38(1):25-30. PubMed ID: 24468566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies in the management of bronchopulmonary dysplasia: the role of corticosteroids.
    Knoppert DC; Mackanjee HR
    Neonatal Netw; 1994 Apr; 13(3):53-60. PubMed ID: 8152411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth in high risk infants <1500 g birthweight during the first 5 weeks.
    Loui A; Tsalikaki E; Maier K; Walch E; Kamarianakis Y; Obladen M
    Early Hum Dev; 2008 Oct; 84(10):645-50. PubMed ID: 18539413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary outcomes in bronchopulmonary dysplasia.
    Bhandari A; Panitch HB
    Semin Perinatol; 2006 Aug; 30(4):219-26. PubMed ID: 16860162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrition and bronchopulmonary dysplasia.
    Dani C; Poggi C
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():37-40. PubMed ID: 23016616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition and outpatient management of the very low-birth-weight infant with bronchopulmonary dysplasia.
    Groothuis JR; Makari D
    Adv Ther; 2012 Apr; 29(4):297-311. PubMed ID: 22529025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selenium status and bronchopulmonary dysplasia in premature infants <1,500 g].
    Merz U; Peschgens T; Dott W; Hörnchen H
    Z Geburtshilfe Neonatol; 1998 Sep; 202(5):203-6. PubMed ID: 9857446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues in nutritional management of very low birth weight infants.
    Hawthorne KM; Griffin IJ; Abrams SA
    Minerva Pediatr; 2004 Aug; 56(4):359-72. PubMed ID: 15457134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.